106 related articles for article (PubMed ID: 11727356)
1. Hemostatic effects of high-dose megestrol acetate therapy in patients with advanced gynecological cancer.
Oberhoff C; Hoffmann O; Winkler UH; Schindler AE
Gynecol Endocrinol; 2001 Oct; 15(5):341-8. PubMed ID: 11727356
[TBL] [Abstract][Full Text] [Related]
2. Effect of high-dose progestogen on hemostatic properties of blood in patients with endometrial cancer.
Kaibara M; Watanabe T; Ooka F; Liang SG; Aisaka K; Okinaga S
Clin Hemorheol Microcirc; 2001; 24(2):93-9. PubMed ID: 11381184
[TBL] [Abstract][Full Text] [Related]
3. [Adjuvant CMF chemotherapy in patients with breast cancer--results on blood coagulation and fibrinolysis].
Oberhoff C; Winkler UH; Tauchert AM; Schindler AE
Zentralbl Gynakol; 1997; 119(5):211-7. PubMed ID: 9281254
[TBL] [Abstract][Full Text] [Related]
4. Hemostatic markers in healthy postmenopausal women during intranasal and oral hormone therapy: a randomized trial.
Hemelaar M; Kenemans P; Hack CE; Klipping C; van der Mooren MJ
Menopause; 2008; 15(2):248-55. PubMed ID: 17693902
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy-induced activation of hemostasis: effect of a low molecular weight heparin (dalteparin sodium) on plasma markers of hemostatic activation.
Weitz IC; Israel VK; Waisman JR; Presant CA; Rochanda L; Liebman HA
Thromb Haemost; 2002 Aug; 88(2):213-20. PubMed ID: 12195692
[TBL] [Abstract][Full Text] [Related]
6. [Effect of high-dose medroxyprogesterone acetate on coagulative and fibrinolytic factors in patients with gynecological cancers].
Ishizaki T; Itoh R; Yasuda J; Yamamoto T; Okada H
Gan To Kagaku Ryoho; 1992 Jun; 19(6):837-42. PubMed ID: 1534983
[TBL] [Abstract][Full Text] [Related]
7. The use of high-dose megestrol acetate in the treatment of ovarian adenocarcinoma.
Geisler HE
Semin Oncol; 1985 Mar; 12(1 Suppl 1):20-2. PubMed ID: 3975647
[TBL] [Abstract][Full Text] [Related]
8. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant antiestrogen treatment with tamoxifen in postmenopausal women with breast cancer: a longitudinal study of blood coagulation and fibrinolysis.
Oberhoff C; Szymeczek J; Hoffmann O; Winkler UH; Kaiser S; Schindler AE
Breast Cancer Res Treat; 1998 Jul; 50(1):73-81. PubMed ID: 9802622
[TBL] [Abstract][Full Text] [Related]
10. Megestrol acetate for the palliation of advanced ovarian carcinoma.
Geisler HE
Obstet Gynecol; 1983 Jan; 61(1):95-8. PubMed ID: 6185891
[TBL] [Abstract][Full Text] [Related]
11. Phase I and pharmacokinetic study of vinblastine and high-dose megestrol acetate.
Matin K; Egorin MJ; Ballesteros MF; Smith DC; Lembersky B; Day RS; Johnson CS; Trump DL
Cancer Chemother Pharmacol; 2002 Sep; 50(3):179-85. PubMed ID: 12203099
[TBL] [Abstract][Full Text] [Related]
12. Coagulation and fibrinolytic profiles and appropriate use of heparin after living-donor liver transplantation.
Kaneko J; Sugawara Y; Tamura S; Togashi J; Matsui Y; Akamatsu N; Kishi Y; Makuuchi M
Clin Transplant; 2005 Dec; 19(6):804-9. PubMed ID: 16313329
[TBL] [Abstract][Full Text] [Related]
13. [Effect of remission induction chemotherapy on blood coagulability in patients with gynecological malignancies].
Sawaguchi K; Yabushita H; Higuchi K; Noguchi M; Ishihara M; Aoyama T; Menjoh H; Oguri T
Nihon Gan Chiryo Gakkai Shi; 1989 Apr; 24(4):798-808. PubMed ID: 2778374
[TBL] [Abstract][Full Text] [Related]
14. Effects of isoflavones on the coagulation and fibrinolytic system of postmenopausal women.
Rios DR; Rodrigues ET; Cardoso AP; Montes MB; Franceschini SA; Toloi MR
Nutrition; 2008 Feb; 24(2):120-6. PubMed ID: 18065202
[TBL] [Abstract][Full Text] [Related]
15. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
16. Use of megestrol acetate in advanced breast cancer on a single-daily-dose schedule.
Carpenter JT; Peterson L
Semin Oncol; 1985 Mar; 12(1 Suppl 1):40-2. PubMed ID: 3975651
[TBL] [Abstract][Full Text] [Related]
17. [Effect of megestrol acetate compound (injectable contraceptive) on human blood coagulation, anticoagulation activity, fibrinolysis and platelet aggregation].
Cheng XF; Shao HZ; Chen ZP
Shengzhi Yu Biyun; 1988; 8(1):22-6. PubMed ID: 12315407
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of selected parameters of blood coagulation and the fibrinolysis system in patients undergoing total hip replacement].
Sokołowska B; Piecuch W; Walter-Croneck A; Dmoszyńska A; Furmanik F
Przegl Lek; 2002; 59(7):502-8. PubMed ID: 12516238
[TBL] [Abstract][Full Text] [Related]
19. Fibronectin plasma levels in gynecological cancers.
Grammatikakis IE; Botsis DC; Grigoriou OV; Dalamanga AN; Creatsas GC
J BUON; 2010; 15(1):122-6. PubMed ID: 20414938
[TBL] [Abstract][Full Text] [Related]
20. Plasma coagulation markers in patients with solid tumors and venous thromboembolic disease receiving oral anticoagulation therapy.
Sallah S; Husain A; Sigounas V; Wan J; Turturro F; Sigounas G; Nguyen NP
Clin Cancer Res; 2004 Nov; 10(21):7238-43. PubMed ID: 15534097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
